iRhythm Technologies, Inc. (LON:0A7L)
London
· Delayed Price · Currency is GBP · Price in USD 142.59
-0.35 (-0.24%)
At close: Jul 3, 2025
iRhythm Technologies Revenue
iRhythm Technologies had revenue of $158.68M USD in the quarter ending March 31, 2025, with 20.27% growth. This brings the company's revenue in the last twelve months to $618.59M, up 20.54% year-over-year. In the year 2024, iRhythm Technologies had annual revenue of $591.84M with 20.13% growth.
Revenue (ttm)
$618.59M
Revenue Growth
+20.54%
P/S Ratio
6.96
Revenue / Employee
$309.29K
Employees
2,000
Market Cap
3.33B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 591.84M | 99.16M | 20.13% |
| Dec 31, 2023 | 492.68M | 81.76M | 19.90% |
| Dec 31, 2022 | 410.92M | 88.10M | 27.29% |
| Dec 31, 2021 | 322.83M | 57.66M | 21.74% |
| Dec 31, 2020 | 265.17M | 50.61M | 23.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| Shell | 217.54B |
| HSBC Holdings | 44.89B |
| Unilever | 50.25B |
| Rolls-Royce Holdings | 18.91B |
| British American Tobacco p.l.c. | 25.87B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
iRhythm Technologies News
- 6 days ago - IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC - Business Wire
- 10 days ago - New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease - GlobeNewsWire
- 16 days ago - Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss - GlobeNewsWire
- 16 days ago - iRhythm Technologies, Inc. (NASDAQ: IRTC) Investor Alert: Schubert Jonckheer & Kolbe LLP Investigating Possible Shareholder Claims for False Statements and Insider Trading - PRNewsWire
- 16 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation - Accesswire
- 18 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation - Accesswire
- 21 days ago - iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 23 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect - Accesswire